| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |